PharmaMar starts a quadruple combination study with Aplidin for the treatment of multiple myeloma

(Pharmamar) PharmaMar announced the start of a multicenter quadruple combination clinical study with Aplidin ® (plitidepsina), along with other compounds for the treatment of multiple myeloma.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Myeloma | Study